Spectrum expands Phase ll trial of poziotinib for NSCLC
Spectrum Pharmaceuticals has expanded its Phase ll clinical trial of poziotinib for the treatment of non-small cell lung cancer (NSCLC)…
NSCLC Spectrum Pharmaceuticals poziotinib
-
-
Spectrum expands Phase ll trial of poziotinib for NSCLC
Spectrum Pharmaceuticals has expanded its Phase ll clinical trial of poziotinib for non-small cell lung cancer (NSCLC) by adding two…
